HCV replication in PBMC and its influence on interferon therapy

doi:10.3748/wjg.v9.i2.291

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3379)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

326

HTML

2704

Figures (1-2)

166

Tables (1-2)

183

Sum=3379

Feb 15, 2003 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (39)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Feb 15, 2003; 9(2): 291-294
Published online Feb 15, 2003. doi: 10.3748/wjg.v9.i2.291

Open in New Tab Full Size Figure Download Figure

Figure 1 Analysis of HCVRNA plus-stand (A) and minus-strand (B). Lane 1, 2, 3, 4, 5: Serum Samples from the patients with hepatitis C. 144bp means plus of minus strand HCVRNA. Lane 6: DNA marker (pGEM-7 HindIII/EcoRI).

Open in New Tab Full Size Figure Download Figure

Figure 2 Indirect immunofluorescent assay for detection of HCV NS5A protein. HCV NS5A was stained in green and distributed mainly in the cytoplasm of PBMCs.

Citation: Gong GZ, Lai LY, Jiang YF, He Y, Su XS. HCV replication in PBMC and its influence on interferon therapy. World J Gastroenterol 2003; 9(2): 291-294
URL: https://www.wjgnet.com/1007-9327/full/v9/i2/291.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i2.291